Technische Universität Dresden
Dresden, Saxony, 0351, Germany
NCT Number: NCT00236171
The purpose of this study is to evaluate the efficacy of the topical therapies Protopic and Advantan as well as their combination against placebo in a Psoriasis Plaque Test
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Dresden, Saxony, 0351, Germany
daily psoriasis plaque tests for two weeks and optical coherence tomography (OCT) and 20-MHz-ultrasound on day 0 and day 11, 10 days post end of treatment and 20 days post end of treatment
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Technische Universität Dresden
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04306315
Psoriasis Vulgaris
Brussels, Belgium
View Trial DetailsNCT03372811
Psoriasis, Psoriasis Vulgaris
New York, United States
View Trial DetailsNCT04340076
Psoriasis, Psoriasis Vulgaris
Brussels, Belgium
View Trial DetailsNCT05442190
Plaque Psoriasis, Psoriasis
San Diego, California, United States
View Trial Details